Who has invested in TrialSpark?

a16z, Sanofi are named among the investors backing TrialSpark.

TrialSpark Funding: $568M Raised, Series D (2024)

TrialSpark funding overview

TrialSpark is based in New York, NY. TrialSpark has raised $568M in total disclosed funding. That places its disclosed total in the $250M–$1B range. Its most recent disclosed round is a Series D announced in June 2024. The round record for TrialSpark runs through 2024; nothing later has been disclosed. Investors on record include a16z, Sanofi. 2 distinct backers are named across the disclosed rounds.

TrialSpark at a glance

Total raised: $568M
Latest round: Series D
Latest round date: June 2024
Headquarters: New York, NY
Notable investors: a16z, Sanofi

Frequently asked about TrialSpark funding

How much has TrialSpark raised?: TrialSpark has raised $568M in total disclosed funding across the rounds on record.
Who has invested in TrialSpark?: a16z, Sanofi are named among the investors backing TrialSpark.
What was the latest TrialSpark funding round?: The most recent disclosed round is a Series D, announced in June 2024.
Where is TrialSpark based?: TrialSpark is based in New York, NY.
When did TrialSpark last raise?: The last disclosed TrialSpark round closed in June 2024 at Series D.

We update the TrialSpark record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related companies in New York and their backers are listed below.

TrialSpark Funding: $568M Raised, Series D (2024)

TrialSpark funding overview

TrialSpark at a glance

Frequently asked about TrialSpark funding

Companies related to TrialSpark (36)

Browse related funding lists (7)